In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
MDR implementation: MD manufacturers to comply with conditions for transition period

MDR implementation: MD manufacturers to comply with conditions for transition period

by In2Pharma | Jul 2, 2024 | News

The Netherlands In 2021, the EU-regulations for medical devices regarding safety and efficacy have become more strict under the implementation of the MDR. This implies that some CE labels have to be updated and a selection of medical devices now need a CE-label, while...

Recent Posts

  • Maximum hospitality limits increased
  • CGR publishes new maximum hourly rates for 2027
  • GAIA self-assessment on hospitality rules now also applies to medical device companies
  • Indexing Issue in Embase: Geneesmiddelenbulletin
  • Update guideline aRMM FAMHP

Follow Us

  • Facebook
  • LinkedIn
An IQVIA Business

IQVIA Logo
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.

www.iqvia.com

Contact Us

Privacy Policy | Your Privacy Choices | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com |Terloonststraat 22, 1910 Kampenhout, België